Gensight market cap

Author: smgl

August undefined, 2024

WebMarket Cap: 112.174M: Beta (5Y Monthly) 2.21: PE Ratio (TTM) N/A: EPS (TTM)-0.6500: Earnings Date: Mar 24, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 9.40 Find out all the key statistics for GenSight Biologics S.A. (SIGHT.PA), including … Stocks sink after Fed minutes despite cooler inflation: Stock market news … PARIS, March 10, 2024--Regulatory News: GenSight Biologics (Euronext: SIGHT, … Find the latest GenSight Biologics S.A. (SIGHT.PA) stock discussion in Yahoo … WebSep 2, 2024 · GenSight at the forefront of Gene Therapy in ophthalmology Publicly traded Biotech company Seasoned management team with strong BioPharma and Financial markets experience Differentiated gene therapy approach forming a technology platform leveraging disruptive gene therapies in ophthalmology and broader

GSGTF GenSight Biologics S.A. Stock Price & News - WSJ

WebMar 29, 2024 · Market Cap €97.6M; Shares Outstanding 46.34M; Public Float 31.92M; Beta N/A; Rev. per Employee €68.42K; P/E Ratio N/A; EPS N/A; Yield N/A; Dividend N/A; Ex … WebMar 24, 2024 · GenSight Biologics S.A. press release ( OTC:GSGTF ): FY GAAP EPS of -€0.63. The Company’s operating income reduced by 36.9% to €4.9 million in 2024 from €7.7 million in 2024. The Company’s... party invitation text messages

GenSight Biologics S.A. (GSGTF) - Yahoo Finance

WebMarket Cap $177.41 M Shares Outstanding 46.34 M Public Float 31.92 M Yield GSGTF is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short … WebApr 3, 2024 · A high-level overview of GenSight Biologics S.A. (GSGTF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebView the latest GenSight Biologics S.A. (GSGTF) stock price, news, historical charts, analyst ratings and financial information from WSJ. tindall infrastructure

GenSight Biologics S.A. has completed an IPO in the amount of …

Gensight market cap

Customer Success and Product Experience Software Gainsight

WebGENSIGHT BIOLOGICS SA Daily – Vickers Top Insider Picks for 12/31/2024 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with... WebView the latest GenSight Biologics S.A. (SIGHT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Did you know?

WebCryptocurrency Prices, Charts And Market Capitalizations CoinMarketCap Today's Cryptocurrency Prices by Market Cap The global crypto market cap is $1.19T, a 1.12% increase over the last day. … WebThis information is intended for investors and the financial community. In this section, we provide investors and the media with pertinent regulatory and financial information as well as news and announcements about the company’s activities

WebView GenSight Biologics S.A.'s Market Cap trends, charts, and more. GenSight Biologics's market cap is €97.557 million... Get the tools used by (smart) 2 investors. WebApr 7, 2024 · SIGHT’s market cap is 106.17 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often …

WebGet the latest Gensight Biologics SA (SIGHT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

WebGenSight Biologics Market Capitalization is currently at 171.79 M. Market Capitalization is the total market value of GenSight Biologics' equity. It is one of many ways to value …

WebReal-time Data is provided using Nasdaq Last Sale Data Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their … tindall high ridgeWebJan 1, 2024 · GenSight Biologics SA Market Capitalization: Historic Market Cap and Yearly Evolution Market Cap GenSight Biologics SA Market Capitalization: €173.2 … party invitation with agendaWebSep 27, 2024 · With a market capitalization of €36m, GenSight Biologics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the … tindall irregular accent wall mirrorWebDec 31, 2024 · 44. Free-Float. 87,2%. More Financials. Company. GenSight Biologics S.A. specializes in the research and development of gene therapies for the treatment of … party invitation wording ideasWebGenSight Biologics SA is a clinical-stage gene therapy company. It is engaged in research and development of novel therapies for mitochondrial and neurodegenerative. The firm also provides ophthalmology services which develops products to restore eyesight to patients suffering from retinal diseases. party invitation word templateWebNov 4, 2024 · GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the " Company "), a biopharma company focused on developing and commercializing innovative gene therapies for retinal … party invite dress codeWebThe average market cap of companies in the sector is 192.3 M with a standard deviation of 297.2 M. GenSight Biologics S.A.'s Market Cap of 178.9 M ranks in the 70.9% percentile … tindall investments llc